REG - MD Medical Group - LAPINO STARTS TREATMENT OF PATIENTS WITH PNEUMONIA

MD Medical InvestmentsAnnouncement

26/03/2020 07:00

RNS Number : 6830H
  
MD Medical Group Investments PLC
  
26 March 2020
  
 

Lapino hospital starts treatment of patients with pneumonia, includng with coronavirus symptoms
 
26 March 2020, Moscow. MD Medical Group Investments Plc ("MD Medical Group," "MDMG," the "Group" or the "Company" - LSE: MDMG), a leading Russian private healthcare provider, announces that it is starting to treat patients with symptoms of pneumonia, including patients with symptoms of coronavirus, in its clinical hospital Lapino. 
In response to the needs of patients the management of the Company took the decision to start treating patients with symptoms of pneumonia, including patients with symptoms of coronavirus at its clinical hospital Lapino from 30 March 2020. The Lapino hospital has all the necessary medical facilities and professional competencies.
 
OBGYN patients, as well as the neonatology service patients, will temporarily receive medical help in the new MD Group Clinical Hospital (PMC) on Sevastopolsky prospect in Moscow which has the customary high standards of medical care characteristic of the Group. Obstetricians from the Lapino hospital will be relocated to the hospital to proceed with all delivery contracts. MD Group Clinical Hospital, which recently went through a major renovation, provides all the conditions for comfortable medical treatments.
 
Surgery, cardiology, traumatology and urology departments of the Lapino Clinical Hospital remain open to receive emergency patients. The paediatric department will continue to operate in normal mode. The Lapino hospital also has a department for pregnant women with signs of acute respiratory viral infections. Hospital work is organised in such a way that patients from different departments will not intersect within the walls of the hospital. The hospital has all the requirements for the autonomous functioning of all of these departments in full compliance with epidemiological standards. 
 
For further information please contact:




Investors


Media




            
Dmitry Yakushkin 
MD Medical Group Investments Plc
Tel: +7 495 332 2011

d.yakushkin@mcclinics.ru




+7 964 714 63 96
pressa@mcclinics.ru
 
 




About MD Medical Group
 
MD Medical Group is a leading provider in the highly attractive Russian private healthcare service market. The company manages 42 modern healthcare facilities, including 6 hospitals and 36 out-patient clinics in Moscow and the Moscow Region, St. Petersburg, Ufa, Perm, Samara and the Samara Region, Irkutsk, Novosibirsk, Irkutsk, Yaroslavl, Ryazan, Kostroma, Novokuznetsk, Krasnoyarsk, Omsk, Barnaul, Vladimir, Tyumen, Voronezh, Nizhny Novgorod, Volgograd, Tula, Kazan, Vladivostok, Krasnodar and Rostov on Don.
 
The Company's shares have been listed on the London Stock Exchange (LSE ticker "MDMG") in the form of Global Depositary Receipts (GDRs) since 12 October 2012.
 
 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
  END
 
 
UPDGLGDXXDDDGGL